REQUEST A DEMO
Total
USD $0.00
Search more companies

Wonbiogen Co., Ltd. (South Korea)

Main Activities: Surgical Appliance and Supplies Manufacturing
Full name: Wonbiogen Co., Ltd. Profile Updated: June 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Wonbiogen Co., Ltd. is based in South Korea. The head office is in Seoul. The enterprise currently operates in the Surgical Appliance and Supplies Manufacturing sector. It was first established on September 03, 2018. It currently has a total number of 72 (2024) employees. The latest financial highlights indicate a net sales revenue increase of 17.97% in Q3C2025. Its’ total assets recorded a growth of 1.08%. The net profit margin of Wonbiogen Co., Ltd. increased by 0.78% in 2025.

Headquarters
97, Uisadang-Daero, Yeongdeungpo-Gu
Seoul; Seoul;

Contact Details: Purchase the Wonbiogen Co., Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Wonbiogen Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Wonbiogen Co., Ltd. report to view the information.
Registered Capital:
Purchase the Wonbiogen Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Wonbiogen Co., Ltd. report to view the information.
Incorporation Date:
September 03, 2018
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
11.9%
Subsidiaries
(주)원바이오젠
Company Performance
Financial values in the chart are available after Wonbiogen Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
17.97%
Total Operating Revenue
18.26%
Operating Profit
21.64%
EBITDA
14.33%
Net Profit/Loss for the Period
22.97%
Total Assets
1.08%
Total Equity
15.46%
Operating Profit Margin
0.69%
Net Profit Margin
0.78%
Return on Equity (ROE)
0.72%
Debt / Equity
-16896%
Quick Ratio
2354.9%
Cash Ratio
1.87%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?